Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Endocrinology · Post-thyroidectomy hypothyroidism

How Often Should TSH Be Checked After Thyroidectomy?

At a Glance

After thyroidectomy, TSH is usually rechecked 4–8 weeks after starting or changing levothyroxine. Once the dose and TSH are stable, testing is commonly done every 6–12 months, but cancer treatment, pregnancy, symptoms, medications, or major weight changes may require earlier checks.

Finding the right dose of thyroid hormone replacement after a total thyroidectomy can feel like a lengthy process of frequent lab visits. However, once your levothyroxine (thyroid hormone replacement) dose is correct and your TSH (thyroid-stimulating hormone) levels are stable, you will not need to have your blood drawn as often. For most patients on a stable dose, the recommended long-term monitoring schedule transitions to about every 6 to 12 months, or anytime your health or symptoms change significantly [1][2].

(Note: If you only had part of your thyroid removed—a lobectomy—your remaining thyroid might produce enough hormone on its own. Your follow-up schedule will be highly individualized [3].)

Here is what you can expect from your TSH monitoring schedule as you move from the initial recovery period into long-term maintenance.

The Dose-Adjustment Phase: Frequent Checks

When you first start taking levothyroxine after surgery, or whenever your dose or medication brand is changed, your care team will typically check your TSH levels about 4 to 8 weeks later [4].

This timeframe is necessary because thyroid hormone builds up and stabilizes slowly in your body. It takes time for a new dose to reach a steady state and for your pituitary gland to adjust its TSH production [4]. Testing any sooner can give an inaccurate picture of how well the dose is working, potentially leading to incorrect adjustments.

Never adjust your dose on your own. Taking your medication consistently—using the same brand, at the same time of day, on an empty stomach—helps ensure your TSH results are accurate and comparable from one test to the next [5].

The Maintenance Phase: Every 6 to 12 Months

Once your TSH levels have remained stable within your target range on an unchanged dose, you enter the maintenance phase. During this time, the frequency of your blood tests drops significantly.

For patients who had surgery for benign (non-cancerous) conditions, doctors typically recommend checking TSH levels every 6 to 12 months for the first year of stability, and then annually thereafter [1]. Routine checks ensure your dose remains appropriate as your body naturally changes with age.

If You Had Differentiated Thyroid Cancer

If your thyroidectomy was a treatment for differentiated thyroid cancer, your target TSH levels and monitoring schedule will look different. Instead of just replacing normal hormone levels, your doctor may aim to keep your TSH slightly below normal (a strategy called TSH suppression) to help reduce the risk of the cancer returning or progressing [6].

For patients with a low risk of cancer recurrence who have had an excellent response to treatment, TSH is often kept in the normal range and monitored about once a year [2]. However, if you have a higher risk of recurrence, your doctor may require tighter suppression and more frequent monitoring [7]. Over time, your doctor will balance the benefits of suppression against potential risks, such as cardiovascular and bone health issues [8].

Keep in mind: TSH monitoring is only one part of your cancer surveillance. Depending on your specific case, your follow-up may also include thyroglobulin (Tg) tests, anti-thyroglobulin antibodies, neck ultrasounds, and physical exams [9].

When to Get Tested Sooner

Even if you are on a stable maintenance schedule, certain life events, health changes, or new medications can alter how your body absorbs or processes thyroid hormone. Contact your doctor to schedule a TSH check—and potentially other tests—if you experience any of the following:

  • Pregnancy: If you become pregnant, your thyroid hormone needs will increase quickly. Contact your care team as soon as pregnancy is confirmed; do not wait for your next routine test. Close monitoring is critical, often requiring a TSH check every 4 weeks during the first half of pregnancy, with prompt dose adjustments to protect your health and fetal development [10][11]. After delivery, your dose will likely need to be reduced again, requiring a postpartum TSH check [12].
  • Return of Hypothyroid Symptoms: If you develop symptoms of underactive thyroid—such as new or worsening fatigue, unexplained weight gain, severe constipation, or cold intolerance—you should have your levels checked [13].
  • Signs of Over-Replacement: Too much thyroid hormone can cause a fast or irregular heartbeat, tremors, heat intolerance, anxiety, insomnia, or unexplained weight loss. Seek urgent medical attention if you experience severe chest pain, fainting, or severe shortness of breath.
  • New Medications or Supplements: Starting or stopping certain medications can interfere with levothyroxine absorption. This includes proton-pump inhibitors, antacids, iron supplements, and calcium [14][15]. Practical tip: Always separate levothyroxine from calcium and iron supplements by at least 4 hours, and ask your pharmacist before combining your dose with other medications.
  • Gastrointestinal Changes: New digestive issues, such as celiac disease, gastritis, or undergoing bariatric surgery, can reduce how well your body absorbs your medication [16].
  • Significant Weight Changes: Because levothyroxine doses are partly based on your body size, major weight loss or weight gain might shift your required dose [17].

Remember, symptoms alone are not enough to confirm a shift in your thyroid levels, so a biochemical blood test is always required before any changes are made to your treatment [13].

Common questions in this guide

How often should TSH be checked after thyroidectomy when my dose is stable?
For most people whose levothyroxine dose and TSH are stable, testing is usually repeated every 6 to 12 months. After the first year of stability, many clinicians continue with annual testing, but your schedule may differ after a lobectomy or thyroid cancer treatment.
When should TSH be tested after starting or changing levothyroxine?
TSH is typically checked about 4 to 8 weeks after starting levothyroxine, changing the dose, or switching brands. Testing sooner may not show the full effect of the change, so do not adjust the dose without your clinician.
Does TSH monitoring change after thyroid cancer treatment?
Yes. After treatment for differentiated thyroid cancer, the target TSH and testing frequency depend on the risk of recurrence and response to treatment; some people need TSH suppression and closer follow-up. Surveillance may also include thyroglobulin blood tests, antibody testing, neck ultrasound, and physical exams.
What changes should prompt an earlier TSH test?
Contact your care team sooner if you become pregnant, develop new thyroid-related symptoms, start or stop medicines or supplements, have digestive problems, undergo bariatric surgery, or have a major weight change. These changes can affect how much levothyroxine your body needs or absorbs.
How does pregnancy affect TSH monitoring after thyroidectomy?
Contact your care team as soon as pregnancy is confirmed rather than waiting for a routine appointment. TSH is often checked about every 4 weeks during the first half of pregnancy, and another check is usually needed after delivery because the dose may need to decrease.
Can symptoms alone show that my thyroid hormone dose needs to change?
Symptoms can suggest that your thyroid hormone dose has changed, but they cannot confirm it because many symptoms have other causes. A blood test is needed before changing treatment; seek urgent help for severe chest pain, fainting, or severe shortness of breath.
How should I take levothyroxine to keep TSH monitoring consistent?
Take levothyroxine consistently, using the same brand and taking it at the same time on an empty stomach unless your clinician instructs otherwise. Separate it from calcium or iron supplements by at least 4 hours, and ask a pharmacist about possible interactions with other medicines.

Get notified when new evidence is published on postsurgical hypothyroidism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.

    Kim SY, Kim HJ, Kim SM, et al.

    Frontiers in endocrinology 2020; (11()):520 doi:10.3389/fendo.2020.00520.

    PMID: 32849303
  2. 2

    An update on the management of low-risk differentiated thyroid cancer.

    Lamartina L, Leboulleux S, Terroir M, et al.

    Endocrine-related cancer 2019; (26(11)):R597-R610.

    PMID: 31484161
  3. 3

    Thyroid hormone replacement following lobectomy: Long-term institutional analysis 15 years after surgery.

    Barranco H, Fazendin J, Lindeman B, et al.

    Surgery 2023; (173(1)):189-192 doi:10.1016/j.surg.2022.05.044.

    PMID: 36202649
  4. 4

    Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.

    Mosaferi T, Tsai K, Sovich S, et al.

    Thyroid : official journal of the American Thyroid Association 2022; (32(5)):496-504 doi:10.1089/thy.2021.0685.

    PMID: 35199588
  5. 5

    Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting.

    Rdzak GM, Whitman LM, Inzucchi SE

    Therapeutic advances in endocrinology and metabolism 2018; (9(7)):217-222 doi:10.1177/2042018818771433.

    PMID: 29977500
  6. 6

    Thyroid hormone therapy in differentiated thyroid cancer.

    Grani G, Ramundo V, Verrienti A, et al.

    Endocrine 2019; (66(1)):43-50 doi:10.1007/s12020-019-02051-3.

    PMID: 31617165
  7. 7

    When Guidelines Meet Reality: The Combined Impact of Assay Variability and Prescribing Differences on TSH Management in Thyroid Cancer.

    Petranović Ovčariček P, Campennì A, D'Aurizio F, et al.

    Cancers 2025; (17(24)) doi:10.3390/cancers17243912.

    PMID: 41463163
  8. 8

    Thyroid-Stimulating Hormone Suppression Therapy in Thyroid Cancer: Balancing Benefits and Harms.

    Pishdad R, Ahmadi S

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(3)):401-405 doi:10.1016/j.eprac.2025.12.002.

    PMID: 41407103
  9. 9

    Follow-up of differentiated thyroid cancer - what should (and what should not) be done.

    Lamartina L, Grani G, Durante C, et al.

    Nature reviews. Endocrinology 2018; (14(9)):538-551 doi:10.1038/s41574-018-0068-3.

    PMID: 30069030
  10. 10

    Outcomes With Levothyroxine Treatment in Early Pregnancy With Subclinical Hypothyroidism.

    Dash SC, Sahoo N, Rout U, et al.

    Cureus 2022; (14(5)):e24984 doi:10.7759/cureus.24984.

    PMID: 35719785
  11. 11

    Management of Hypothyroidism and Hypothyroxinemia During Pregnancy.

    Pearce EN

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(7)):711-718 doi:10.1016/j.eprac.2022.05.004.

    PMID: 35569735
  12. 12

    Levothyroxine Dosage Requirement During Pregnancy in Well-Controlled Hypothyroid Women: A Longitudinal Study.

    Kashi Z, Bahar A, Akha O, et al.

    Global journal of health science 2015; (8(4)):227-33 doi:10.5539/gjhs.v8n4p227.

    PMID: 26573046
  13. 13

    Hypothyroidism.

    Taylor PN, Medici MM, Hubalewska-Dydejczyk A, Boelaert K

    Lancet (London, England) 2024; (404(10460)):1347-1364 doi:10.1016/S0140-6736(24)01614-3.

    PMID: 39368843
  14. 14

    ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.

    Guglielmi R, Frasoldati A, Zini M, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(11)):1319-1326 doi:10.4158/EP161308.OR.

    PMID: 27482609
  15. 15

    Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

    Caron P, Grunenwald S, Persani L, et al.

    Reviews in endocrine & metabolic disorders 2022; (23(3)):463-483 doi:10.1007/s11154-021-09691-9.

    PMID: 34671932
  16. 16

    Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

    Centanni M, Benvenga S, Sachmechi I

    Journal of endocrinological investigation 2017; (40(12)):1289-1301 doi:10.1007/s40618-017-0706-y.

    PMID: 28695483
  17. 17

    Analysis of factors influencing the dose of levothyroxine treatment in adequately controlled hypothyroid patients of different etiologies.

    Stempler M, Bakos B, Solymosi T, et al.

    Heliyon 2024; (10(20)):e39639 doi:10.1016/j.heliyon.2024.e39639.

    PMID: 39502224

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist or surgeon should set your TSH target and testing schedule based on your thyroidectomy, cancer history, pregnancy plans, and overall health.